Nestlé India Faces 3 FSSAI Cases Over ‘Easy-To-Digest’ Whey Claim, Biotin Levels
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.4 Articles
4 Articles
India's Food Safety Authority (FSSAI) determined that the biotin content in Nestlé's infant follow-up formula products fell short of the standard, and initiated 3 legal proceedings against Nestlé on the 18th. FSSAI stated that Nestlé's follow up formula samples were “defective products that do not meet biotin standards.” Biotin is a nutrient also known as vitamin B7, and FSSAI defines the standard content range applied to baby food products, and…
Is Nestlé A Dangerous Brand? From Lactogen And Cerelac In India To Formula Investigations Abroad, Why Does Its Infant-Nutrition Business Keep Coming Under Scrutiny?
Nestlé India is facing fresh regulatory action over the way it markets some of its infant nutrition products, with the Food Safety and Standards Authority of India filing three adjudication cases concerning NAN Excella Pro Stage 1 and Lactogen Pro 1. The action follows scrutiny of promotional material and product listings on e-commerce platforms, putting …
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
